Similar articles for PMID: 12389844

Year	Number of Results
1998	1
2002	5
2003	1
2004	7
2005	6
2006	7
2007	7
2008	5
2009	3
2024	0

1

Oral contraceptives and the risk of breast cancer.

Farquhar D. Farquhar D. CMAJ. 2002 Oct 1;167(7):782. CMAJ. 2002. PMID: 12389844 Free PMC article. No abstract available.

2

Oral contraceptives and the risk of death from breast cancer.

Wingo PA, Austin H, Marchbanks PA, Whiteman MK, Hsia J, Mandel MG, Peterson HB, Ory HW. Wingo PA, et al. Obstet Gynecol. 2007 Oct;110(4):793-800. doi: 10.1097/01.AOG.0000284446.22251.6e. Obstet Gynecol. 2007. PMID: 17906011

3

Effect of reproductive factors and oral contraceptives on breast cancer risk in BRCA1/2 mutation carriers and noncarriers: results from a population-based study.

Lee E, Ma H, McKean-Cowdin R, Van Den Berg D, Bernstein L, Henderson BE, Ursin G. Lee E, et al. Cancer Epidemiol Biomarkers Prev. 2008 Nov;17(11):3170-8. doi: 10.1158/1055-9965.EPI-08-0396. Cancer Epidemiol Biomarkers Prev. 2008. PMID: 18990759

4

Absence of an effect of injectable and implantable progestin-only contraceptives on subsequent risk of breast cancer.

Strom BL, Berlin JA, Weber AL, Norman SA, Bernstein L, Burkman RT, Daling JR, Deapen D, Folger SG, Malone KE, Marchbanks PA, Simon MS, Ursin G, Weiss LK, Spirtas R. Strom BL, et al. Contraception. 2004 May;69(5):353-60. doi: 10.1016/j.contraception.2003.12.015. Contraception. 2004. PMID: 15105056

5

The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.

Menendez JA, Oza BP, Colomer R, Lupu R. Menendez JA, et al. Int J Oncol. 2005 Jun;26(6):1507-15. Int J Oncol. 2005. PMID: 15870863

6

20. Oral contraceptives, hormone replacement therapy and breast cancer.

Fentiman IS. Fentiman IS. Int J Clin Pract. 2002 Dec;56(10):755-9. Int J Clin Pract. 2002. PMID: 12510949 Review.

7

Oral contraceptive use and risk of breast cancer among women with a family history of breast cancer: a prospective cohort study.

Silvera SA, Miller AB, Rohan TE. Silvera SA, et al. Cancer Causes Control. 2005 Nov;16(9):1059-63. doi: 10.1007/s10552-005-0343-1. Cancer Causes Control. 2005. PMID: 16184471

8

The risk of breast, endometrial and ovarian cancer in users of hormonal preparations.

Bernstein L. Bernstein L. Basic Clin Pharmacol Toxicol. 2006 Mar;98(3):288-96. doi: 10.1111/j.1742-7843.2006.pto_277.x. Basic Clin Pharmacol Toxicol. 2006. PMID: 16611204 Free article. Review.

9

[Oral contraceptives and breast cancer].

Zoricić D, Ambrozić B, Perić D. Zoricić D, et al. Lijec Vjesn. 1998 Dec;120(12):392-7. Lijec Vjesn. 1998. PMID: 19658362 Review. Croatian.

10

Risk of breast cancer associated with short-term use of oral contraceptives.

Folger SG, Marchbanks PA, McDonald JA, Bernstein L, Ursin G, Berlin JA, Daling JR, Norman SA, Strom BL, Weiss LK, Simon MS, Burkman RT, Malone KE, Spirtas R. Folger SG, et al. Cancer Causes Control. 2007 Mar;18(2):189-98. doi: 10.1007/s10552-006-0086-7. Epub 2007 Jan 10. Cancer Causes Control. 2007. PMID: 17216547

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

41 results

Results by year